CLPBF (Coloplast AS) Total Liabilities: $5,229 Mil (As of Mar. 2026)


CLPBF Coloplast AS CLPBF
72 GF Score
Price $57.41
GF Value $125.62
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Coloplast AS Total Liabilities?

Coloplast AS CLPBF 72 Total Liabilities is $5,229 Mil as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $125.62 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Coloplast AS's Total Liabilities for the quarter that ended in Mar. 2026 was $5,229 Mil.

Coloplast AS's quarterly Total Liabilities increased from Sep. 2025 ($5,070.77 Mil) to Dec. 2025 ($5,486.02 Mil) but then declined from Dec. 2025 ($5,486.02 Mil) to Mar. 2026 ($5,228.84 Mil).

Coloplast AS's annual Total Liabilities increased from Sep. 2023 ($4,416.33 Mil) to Sep. 2024 ($4,485.12 Mil) and increased from Sep. 2024 ($4,485.12 Mil) to Sep. 2025 ($5,070.77 Mil).

Coloplast AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Total Liabilities Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,213.97 3,878.41 4,416.33 4,485.12 5,070.77

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,668.59 4,859.62 5,070.77 5,486.02 5,228.84
CLPBF
72GF Score
Coloplast AS CLPBF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Coloplast AS's Total Liabilities for the fiscal year that ended in Sep. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1022.96+(3152.854+483.252
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+17.456+394.244)
=5,071

Total Liabilities=Total Assets (A: Sep. 2025 )-Total Equity (A: Sep. 2025 )
=7606.07-2535.304
=5,071

Coloplast AS's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=924.783+(3402.162+505.004
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+17.478+394.244)
=5,229

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=7215.288-1986.451
=5,229

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $5,229 Mil mean?
Coloplast AS (CLPBF) has a Total Liabilities of $5,229 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Coloplast AS and its competitors.
Is Coloplast AS's Total Liabilities too high?
Coloplast AS's current Total Liabilities is $5,229 Mil. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Total Liabilities compare to ISRG and BDX?
Coloplast AS's Total Liabilities of $5,229 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Coloplast AS and its competitors. Coloplast AS's current Total Liabilities is $5,229 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $125.62, compared to a current price of $57.41 — trading 54.3% below its estimated fair value. The current Total Liabilities is $5,229 Mil. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Total Liabilities is $5,229 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBF) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $57.41 is trading 54.3% below its estimated GF Value™ of $125.62. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBF:

  • Total Liabilities: $5,229 Mil
  • GF Value™: $125.62 vs. price of $57.41 (54.3% below fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score

Get the complete analysis for CLPBF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$57.41
Price
$125.62
GF Value